It’s not easy being one of Silicon Valley’s favorite benchmarks.

Pharmaceutical company Eli Lilly is looking to roll out a daily weight loss pill for patients with obesity and type 2 ...

A new oral GLP-1 medication can help adults with obesity and Type 2 diabetes lose more weight and improve their blood sugar ...

Each year, millions of people turn to diet pills to lose weight. As of 2022, about 15 percent of U.S. adults reported using a weight-loss supplement at some point in their lives. One popular ...

Long before he found himself in the middle of a multibillion-dollar takeover battle for a coveted new weight-loss drug, Whit Bernard was a music nerd. He spent two years studying the role of musical ...

Eli Lilly & Co. has already produced billions of doses of its next-generation weight-loss pill, anticipating massive global demand ahead of a potential launch next year. “We’ve already made, actually, ...

Orforglipron is an oral medication currently being developed for obesity and type 2 diabetes. Similar to glucagon-like peptide-1 (GLP-1) receptor agonist injections, the pill may help reduce appetite, ...

EAST PROVIDENCE, R.I. (WPRI) — A weight loss pill may become available by the end of this year or early in 2026. Dr. Ashish Jha, dean of Brown University’s School of Public Health, joined 12 News at 4 ...

Glucagon-like peptide-1 receptor agonists (GLP-1RAs) currently available for the treatment of obesity are administered as a peptide-based subcutaneous injection, but oral (non-peptide) versions would ...

GLP-1 medications have been a life-changing tool to help people manage their blood sugar and lose weight. But the most popular forms of these medications have a big drawback: you have to inject ...

Ozempic Insulin box and injection pen or insulin cartridge pen for diabetes patients from Novo Nordisk. Blurred pharmacy background. Copenhagen, Denmark - January 29, 2024. A semaglutide pill is ...

A pill form of the weight loss drug Wegovy was as effective as injections for people with obesity in a clinical trial, the drug's manufacturer said. Novo Nordisk said in its news release that ...